Morepen Laboratories consolidated net profit declines 53.96% in the March 2022 quarter

5 May 2022 , 02:14 PM

Net profit of Morepen Laboratories declined 53.96% to Rs 12.32 crore in the quarter ended March 2022 as against Rs 26.76 crore during the previous quarter ended March 2021. Sales rose 28.50% to Rs 368.28 crore in the quarter ended March 2022 as against Rs 286.60 crore during the previous quarter ended March 2021. For the full year,net profit rose 4.73% to Rs 101.68 crore in the year ended March 2022 as against Rs 97.09 crore during the previous year ended March 2021. Sales rose 30.20% to Rs 1546.83 crore in the year ended March 2022 as against Rs 1188.06 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	368.28	286.60	28	1546.83	1188.06	30
OPM %	5.07	10.61	–	8.84	9.98	–
PBDT	21.06	34.62	-39	154.35	128.79	20
PBT	14.18	27.63	-49	126.70	98.51	29
NP	12.32	26.76	-54	101.68	97.09	5

Powered by Capital Market – Live News